Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

[Brachytherapy for oesophageal cancer].

Wong S, Hennequin C, Quero L.

Cancer Radiother. 2013 Apr;17(2):159-61. doi: 10.1016/j.canrad.2013.03.003. Epub 2013 Apr 18. Review. French.

PMID:
23603254
2.

Interventions for dysphagia in oesophageal cancer.

Sreedharan A, Harris K, Crellin A, Forman D, Everett SM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005048. doi: 10.1002/14651858.CD005048.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD005048.

PMID:
19821338
3.

Palliation of malignant dysphagia from oesophageal cancer. Rotterdam Oesophageal Tumor Study Group.

Siersema PD, Dees J, van Blankenstein M.

Scand J Gastroenterol Suppl. 1998;225:75-84. Review.

PMID:
9515757
4.

WITHDRAWN: Interventions for dysphagia in oesophageal cancer.

Sreedharan A, Harris K, Crellin A, Forman D, Everett SM.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005048. doi: 10.1002/14651858.CD005048.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD005048.

PMID:
21328271
5.

Interventions for dysphagia in oesophageal cancer.

Dai Y, Li C, Xie Y, Liu X, Zhang J, Zhou J, Pan X, Yang S.

Cochrane Database Syst Rev. 2014 Oct 30;(10):CD005048. doi: 10.1002/14651858.CD005048.pub4. Review.

PMID:
25354795
6.

The use of self-expandable metallic stents for palliative treatment of inoperable esophageal cancer.

Eroglu A, Turkyilmaz A, Subasi M, Karaoglanoglu N.

Dis Esophagus. 2010 Jan;23(1):64-70. doi: 10.1111/j.1442-2050.2009.00978.x. Epub 2009 May 15.

PMID:
19473204
7.

Palliative therapy.

Homs MY, Kuipers EJ, Siersema PD.

J Surg Oncol. 2005 Dec 1;92(3):246-56. Review.

PMID:
16299791
9.

Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study.

Spencer GM, Thorpe SM, Blackman GM, Solano J, Tobias JS, Lovat LB, Bown SG.

Gut. 2002 Feb;50(2):224-7.

10.

Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency.

Rosenblatt E, Jones G, Sur RK, Donde B, Salvajoli JV, Ghosh-Laskar S, Frobe A, Suleiman A, Xiao Z, Nag S.

Radiother Oncol. 2010 Dec;97(3):488-94. doi: 10.1016/j.radonc.2010.09.001. Epub 2010 Oct 13.

PMID:
20950882
11.

Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.

Bergquist H, Johnsson E, Nyman J, Rylander H, Hammerlid E, Friesland S, Ejnell H, Lundell L, Ruth M.

Dis Esophagus. 2012 Jul;25(5):410-5. doi: 10.1111/j.1442-2050.2011.01248.x. Epub 2011 Sep 7.

PMID:
21899654
12.

Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.

Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD.

Gastrointest Endosc. 2012 Aug;76(2):267-74. doi: 10.1016/j.gie.2012.04.442. Epub 2012 Jun 12.

PMID:
22695208
13.

New developments in palliative therapy.

Siersema PD.

Best Pract Res Clin Gastroenterol. 2006;20(5):959-78. Review.

PMID:
16997172
14.
15.

Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review.

Amdal CD, Jacobsen AB, Guren MG, Bjordal K.

Acta Oncol. 2013 May;52(4):679-90. doi: 10.3109/0284186X.2012.731521. Epub 2012 Nov 28. Review.

PMID:
23190360
16.

Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy.

Grazziotin Reisner R, Reisner ML, Ferreira MA, Rosa AA, Veras IM, Carneiro TM, Wolff B, Viégas CM, Mendonça de Araújo CM, Marchiori E.

Brachytherapy. 2015 Jan-Feb;14(1):84-90. doi: 10.1016/j.brachy.2014.09.007. Epub 2014 Oct 30.

PMID:
25447340
17.
18.

Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II).

Rupinski M, Zagorowicz E, Regula J, Fijuth J, Kraszewska E, Polkowski M, Wronska E, Butruk E.

Am J Gastroenterol. 2011 Sep;106(9):1612-20. doi: 10.1038/ajg.2011.178. Epub 2011 Jun 14.

PMID:
21670770
19.

Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.

Wenger U, Johnsson E, Bergquist H, Nyman J, Ejnell H, Lagergren J, Ruth M, Lundell L.

Eur J Gastroenterol Hepatol. 2005 Dec;17(12):1369-77.

PMID:
16292092
20.

Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.

Sur RK, Donde B, Levin VC, Mannell A.

Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):447-53.

PMID:
9457834

Supplemental Content

Support Center